Aurora Cannabis (ACB) Net Margin (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Net Margin of 6.58% for Q1 2026, down 1331.0% year-on-year from 0.53% in Q1 2025, and down 53.42% on a QoQ basis from 14.13% in Q4 2025.
Aurora Cannabis (ACB) Net Margin (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Net Margin for 10 consecutive years, with 6.58% the latest figure, recorded in Q1 2026.
- Quarterly Net Margin fell 1331.0% year-over-year to 6.58% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 263.76% (down 1.0% YoY) and the FY2026 annual result came in at 18.28%, down 21460.0% from the prior year.
- Net Margin declined to 6.58% in Q1 2026 per ACB's latest filing, from 14.13% in the prior quarter.
- Over the last five years, Net Margin for ACB reached as high as 2160.42% in Q1 2022 and fell as low as 1243.97% in Q2 2022.
- A 5-year average of 193.73% and a median of 83.68% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin slumped 368732 bps — and 2023, when it soared 132163 bps.
- Year by year, Net Margin stood at 461.89% in 2022, then soared by 274 bps to 802.25% in 2023, then fell by 19 bps to 649.58% in 2024, then plunged by 98 bps to 14.13% in 2025, then slumped by 53 bps to 6.58% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 6.58%, 14.13%, and 588.62% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 6.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.58% |
| Dec 31, 2025 | 14.13% |
| Sep 30, 2025 | 588.62% |
| Jun 30, 2025 | 563.05% |
| Mar 31, 2025 | 19.89% |
| Dec 31, 2024 | 649.58% |
| Sep 30, 2024 | 308.66% |
| Jun 30, 2024 | 206.34% |
| Mar 31, 2024 | -3.31% |
| Dec 31, 2023 | 802.25% |
| Sep 30, 2023 | 89.69% |
| Jun 30, 2023 | 77.67% |
| Dec 31, 2022 | -461.89% |
| Sep 30, 2022 | -677.97% |
| Jun 30, 2022 | -1,243.97% |
| Mar 31, 2022 | 2,160.42% |
| Dec 31, 2021 | 3,225.43% |
| Sep 30, 2021 | -25.14% |
| Jun 30, 2021 | 56.82% |
| Mar 31, 2021 | 3,948.60% |